WATERTOWN, Mass., Sept. 10, 2020 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ:ALRN) today announced that Manuel Aivado, M.D., Ph.D., President and […]
-NTAP designation highlights need for novel antibiotics to fight drug-resistant infections and advance antimicrobial stewardship-CONTEPO first Qualified Infectious Disease Product […]